These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19799559)

  • 1. Modeling dependence in methylation patterns with application to ovarian carcinomas.
    Lacey MR; Ehrlich M
    Stat Appl Genet Mol Biol; 2009; 8():Article 40. PubMed ID: 19799559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both hypomethylation and hypermethylation in a 0.2-kb region of a DNA repeat in cancer.
    Nishiyama R; Qi L; Lacey M; Ehrlich M
    Mol Cancer Res; 2005 Nov; 3(11):617-26. PubMed ID: 16317087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A DNA repeat, NBL2, is hypermethylated in some cancers but hypomethylated in others.
    Nishiyama R; Qi L; Tsumagari K; Weissbecker K; Dubeau L; Champagne M; Sikka S; Nagai H; Ehrlich M
    Cancer Biol Ther; 2005 Apr; 4(4):440-8. PubMed ID: 15846090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
    Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
    Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemimethylation footprints of DNA demethylation in cancer.
    Shao C; Lacey M; Dubeau L; Ehrlich M
    Epigenetics; 2009 Apr; 4(3):165-75. PubMed ID: 19287214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation and ovarian cancer. I. Analysis of CpG island hypermethylation in human ovarian cancer using differential methylation hybridization.
    Ahluwalia A; Yan P; Hurteau JA; Bigsby RM; Jung SH; Huang TH; Nephew KP
    Gynecol Oncol; 2001 Aug; 82(2):261-8. PubMed ID: 11531277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Methylation Patterns with Long Read Sequencing Data.
    Meyer KN; Lacey MR
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(4):1379-1389. PubMed ID: 28682263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.
    Houshdaran S; Hawley S; Palmer C; Campan M; Olsen MN; Ventura AP; Knudsen BS; Drescher CW; Urban ND; Brown PO; Laird PW
    PLoS One; 2010 Feb; 5(2):e9359. PubMed ID: 20179752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers.
    Wei SH; Chen CM; Strathdee G; Harnsomburana J; Shyu CR; Rahmatpanah F; Shi H; Ng SW; Yan PS; Nephew KP; Brown R; Huang TH
    Clin Cancer Res; 2002 Jul; 8(7):2246-52. PubMed ID: 12114427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in human epigenomes depends on local topology of CpG sites.
    Lövkvist C; Dodd IB; Sneppen K; Haerter JO
    Nucleic Acids Res; 2016 Jun; 44(11):5123-32. PubMed ID: 26932361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
    Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide de novo methylation in epithelial ovarian cancer.
    Michaelson-Cohen R; Keshet I; Straussman R; Hecht M; Cedar H; Beller U
    Int J Gynecol Cancer; 2011 Feb; 21(2):269-79. PubMed ID: 21270610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMM-Fisher: identifying differential methylation using a hidden Markov model and Fisher's exact test.
    Sun S; Yu X
    Stat Appl Genet Mol Biol; 2016 Mar; 15(1):55-67. PubMed ID: 26854292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant Hypomethylation of Solute Carrier Family 6 Member 12 Promoter Induces Metastasis of Ovarian Cancer.
    Sung HY; Yang SD; Park AK; Ju W; Ahn JH
    Yonsei Med J; 2017 Jan; 58(1):27-34. PubMed ID: 27873492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Mathematical Model for Inheritance of DNA Methylation Patterns in Somatic Cells.
    Utsey K; Keener JP
    Bull Math Biol; 2020 Jul; 82(7):84. PubMed ID: 32613387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hidden markov model for identifying differentially methylated sites in bisulfite sequencing data.
    Shokoohi F; Stephens DA; Bourque G; Pastinen T; Greenwood CMT; Labbe A
    Biometrics; 2019 Mar; 75(1):210-221. PubMed ID: 30168593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acquisition of hMLH1 methylation in plasma DNA after chemotherapy predicts poor survival for ovarian cancer patients.
    Gifford G; Paul J; Vasey PA; Kaye SB; Brown R
    Clin Cancer Res; 2004 Jul; 10(13):4420-6. PubMed ID: 15240532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation Linear Discriminant Analysis (MLDA) for identifying differentially methylated CpG islands.
    Dai W; Teodoridis JM; Graham J; Zeller C; Huang TH; Yan P; Vass JK; Brown R; Paul J
    BMC Bioinformatics; 2008 Aug; 9():337. PubMed ID: 18691414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes.
    Hattori M; Sakamoto H; Satoh K; Yamamoto T
    Cancer Lett; 2001 Aug; 169(2):155-64. PubMed ID: 11431104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.